Description
Book SynopsisAn increasing number of pharmaceuticals in human and veterinary medicine are being developed using advanced genetic and other methods that focus on modification of somatic and embryonic cells.
Trade ReviewExcerpt from Foreword by Keith L. Carson, Chairman, Williamsburg BioProcessing Foundation (WilBio):
"This book provides an anthology of information in essentially all areas of bioprocessing...(and it) provides essential information on proven techniques that can make the evolutionary art form of biologic manufacturing more manageable...I know you will enjoy this book and find its information to be highly valuable for your work. Whether you are a beginner in this field or a seasoned veteran, this text will give you the reference material you need to successfully develop and produce biologics, while satisfying regulatory requirements."
Table of ContentsContributors.
Preface.
Foreword.
Chapter 1: Overview of the Biopharmaceutical Industry.
Chapter 2: Regulatory Requirements for Processing Biopharmaceuticals.
Chapter 3: Genomics, Proteomics, and Metabolomics – Impact on Biopharmaceutical Processing.
Chapter 4: New Technologies in Biopharmaceutical Upstream Processing.
Chapter 5: New Technologies in Biopharmaceutical Downstream Processing.
Chapter 6: Biopharmaceutical Product Formulation, Preservation, and Presentation.
Chapter 7: Biopharmaceutical Product and Process Monitoring, Analysis and Control.
Chapter 8: Discrete Automation in BioProcessing Unit Operations.
Chapter 9: Emerging Biopharmaceutical Platforms.
Bibliography and Further Reading.
Index
